FDA Inspection 1037421 — G.D. Searle, LLC
The FDA completed an inspection of G.D. Searle, LLC on Dec 20, 2017 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 20, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- New York, NY (United States)
Additional details
Sponsor, Contract Research Organization